Skip to content
★ Sign in to follow
SC

Simon Chin

Iris Biotechnologies Inc
Total declarations
108
Company
1
▲ Purchases (65 ops.)
€31k
▼ Sales (25 ops.)
€33k

Latest filing published 21 Dec 2017 for IRIS BIOTECHNOLOGIES INC, €26k.

Filing timeline

BuySale
Simon Chin

Insider track record

Disclosed buys
65
Disclosed sells
25
Signal history

Closed purchases

Market purchases
65

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Simon Chin: trading record in brief

This profile gathers the share dealings of Simon Chin in Iris Biotechnologies Inc. Over a trading history stretching from 4 August 2008 to 20 December 2017, the count stands at 108 filings.

The open-market side counts 65 purchases for €31k alongside 25 sales for €33k. The net balance comes to €1,781 on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise.

In size, the median ticket on the buying side is €153.

The record was last updated on 21 December 2017 with a transaction (€26k) in Iris Biotechnologies Inc. The most recent open-market purchase was published on 30 December 2015, 3,966 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Simon Chin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations105 total
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    31,248 USD23SEC
    390,600 shares@ US$0.085.7% of flowCommon StockSEC:0001554795-17-000425:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    41,667 USD23SEC
    347,222 shares@ US$0.127.7% of flowCommon StockSEC:0001554795-17-000415:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    31,250 USD23SEC
    312,500 shares@ US$0.105.7% of flowCommon StockSEC:0001554795-17-000363:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    41,667 USD23SEC
    416,670 shares@ US$0.107.7% of flowCommon StockSEC:0001554795-17-000328:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    41,667 USD23SEC
    198,413 shares@ US$0.218.0% of flowCommon StockSEC:0001554795-17-000239:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    62,500 USD23SEC
    339,674 shares@ US$0.18412.8% of flowCommon StockSEC:0001554795-17-000091:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    41,665 USD23SEC
    320,500 shares@ US$0.138.6% of flowCommon StockSEC:0001554795-16-001000:0
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    631 USD22SEC
    5,650 shares@ US$0.11160.1% of flowCommon StockSEC:0001554795-16-000968:2
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    1,100 USD22SEC
    10,000 shares@ US$0.110.2% of flowCommon StockSEC:0001554795-16-000968:3
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    300 USD22SEC
    2,500 shares@ US$0.120.1% of flowCommon StockSEC:0001554795-16-000968:4
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    2,750 USD22SEC
    27,500 shares@ US$0.100.6% of flowCommon StockSEC:0001554795-16-000968:5
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    950 USD22SEC
    11,881 shares@ US$0.080.2% of flowCommon StockSEC:0001554795-16-000968:6
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    910 USD22SEC
    10,000 shares@ US$0.0910.2% of flowCommon StockSEC:0001554795-16-000968:7
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    285 USD22SEC
    2,500 shares@ US$0.1140.1% of flowCommon StockSEC:0001554795-16-000968:8
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    900 USD22SEC
    10,000 shares@ US$0.090.2% of flowCommon StockSEC:0001554795-16-000968:9
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    1,140 USD22SEC
    10,000 shares@ US$0.1140.2% of flowCommon StockSEC:0001554795-16-000968:10
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    900 USD22SEC
    10,000 shares@ US$0.090.2% of flowCommon StockSEC:0001554795-16-000968:11
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    123 USD22SEC
    1,250 shares@ US$0.0980.0% of flowCommon StockSEC:0001554795-16-000968:12
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    1,600 USD22SEC
    20,000 shares@ US$0.080.3% of flowCommon StockSEC:0001554795-16-000968:13
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    190 USD22SEC
    1,250 shares@ US$0.1520.0% of flowCommon StockSEC:0001554795-16-000968:0
  • ▼
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    2,610 USD22SEC
    21,750 shares@ US$0.120.5% of flowCommon StockSEC:0001554795-16-000968:1
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    83,333 USD24SEC
    416,667 shares@ US$0.2016.3% of flowCommon StockSEC:0001554795-16-000897:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    0SEC
    50,000 shares0Common StockSEC:0001554795-16-000762:0
  • ●
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    125,000 USD24SEC
    1,041,667 shares@ US$0.1224.6% of flowCommon StockSEC:0001554795-16-000762:1
  • ▲
    Chief Executive OfficerExecutivesIris Biotechnologies Inc
    22 USD0SEC
    100 shares@ US$0.2249Common StockSEC:0001554795-15-000507:0
    Canonical exit: 14 Mar 2016 (T+90)

25 of 105 declarations